Soluble ST2 as a Useful Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients.

Park M, Hur M, Kim H, Lee CH, Lee JH, Kim HW, Nam M, Lee S.

Open source

DOI
10.3390/diagnostics13020259
Published
2023-01-10
Container
Diagnostics (Basel)
Publisher
Not recorded
Open access
yes

Credibility signals

uncertain Score 53/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/diagnostics13020259,
  title = {Soluble ST2 as a Useful Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients.},
  author = {Park M and  Hur M and  Kim H and  Lee CH and  Lee JH and  Kim HW and  Nam M and  Lee S.},
  year = {2023},
  journal = {Diagnostics (Basel)},
  doi = {10.3390/diagnostics13020259},
  url = {https://doi.org/10.3390/diagnostics13020259}
}

RIS

TY  - JOUR
TI  - Soluble ST2 as a Useful Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients.
AU  - Park M
AU  -  Hur M
AU  -  Kim H
AU  -  Lee CH
AU  -  Lee JH
AU  -  Kim HW
AU  -  Nam M
AU  -  Lee S.
PY  - 2023
JO  - Diagnostics (Basel)
DO  - 10.3390/diagnostics13020259
UR  - https://doi.org/10.3390/diagnostics13020259
ER  - 

APA

M, P., M, H., H, K., CH, L., JH, L., HW, K., M, N., & S., L. (2023). Soluble ST2 as a Useful Biomarker for Predicting Clinical Outcomes in Hospitalized COVID-19 Patients.. Diagnostics (Basel). https://doi.org/10.3390/diagnostics13020259

Source records